Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
John K. Clarke Insider Profile
4 Followers
John K. Clarke, Director at Momenta Pharma, holds 19.80K shares in aTyr Pharma (Ticker: LIFE), holds 8.89K shares in Alnylam Pharma (Ticker: ALNY), holds 69.12K shares in Momenta Pharma (Ticker: MNTA). Most recently, John K. Clarke Sold ― shares of aTyr Pharma on May 25, 2021 for an estimated value of 10.85K.
Profitable Transactions
2 out of 4 Profitable Transactions
Average Return
+2.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that John K. Clarke holds in companies
Most Profitable Insider Trade
Stock:
Momenta Pharma
(MNTA)
(MNTA)
Rating:Informative Sell
Date:May 13, 2015 - May 13, 2016
Return:+50.30%
The most profitable trade made by John K. Clarke
John K. Clarke's Trading History
Momenta Pharma
May 13, 2015
―
Informative Sell
766.46K
$3.63M
aTyr Pharma
May 25, 2021
Director
Informative Sell
10.85K
$33.46K
Alnylam Pharma
Jun 04, 2018
Director
Uninformative Sell
1.50M
$1.35M
Verastem
Jun 13, 2013
Director
Informative Buy
222.21K
$26.55M
List of latest transactions for each holding click on a transaction to see John K. Clarke's performance on stock
You May Also Like
John K. Clarke insider profile FAQ
What is the percentage of profitable transactions made by John K. Clarke?
The percentage of profitable transactions made by John K. Clarke is 50%.
What is the average return per transaction made by John K. Clarke?
The average return per transaction made by John K. Clarke is 2.30%.
What stocks does John K. Clarke hold?
John K. Clarke holds: MNTA, LIFE, ALNY, VSTM stocks.
What was John K. Clarke’s latest transaction?
John K. Clarke latest transaction was an Informative Sell of $10.85K.
What was John K. Clarke's most profitable transaction?
John K. Clarke’s most profitable transaction was an Informative Sell of MNTA stock on May 13, 2015. The return on the trade was 50.30%.
What is John K. Clarke's role in Momenta Pharma?
John K. Clarke's role in Momenta Pharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.